Quick Read
Acute gastrointestinal bleeding is a blood-loss problem and a localisation problem at the same time. The person may present with haematemesis, melaena, haematochezia, syncope, anaemia or shock, but the visible output does not always identify the source with certainty.
The distinct Medicine Web job is: overt bleeding or suspected acute blood loss → haemodynamic assessment and resuscitation → upper/lower/uncertain source classification → laboratory and medication context → endoscopy/CT angiography/other localisation → endoscopic, radiological or surgical haemostasis → transfusion and antithrombotic decisions → rebleeding surveillance → cause treatment → recurrence prevention and functional return.
Wait, What? Bright Red Blood Does Not Always Mean the Bleeding Is Low in the Bowel
Haematochezia often suggests lower-GI bleeding, but brisk upper-GI bleeding can also present with red blood per rectum. Melaena often suggests an upper source, yet right-sided colonic bleeding can occasionally darken stool. The first visible sign is evidence—not final localisation.
Core anti-collapse rules: haematemesis ≠ one cause; melaena ≠ upper source proven in every case; haematochezia ≠ lower source proven; low haemoglobin ≠ active bleeding rate; transfusion ≠ haemostasis; endoscopy done ≠ rebleeding risk gone.
The Acute GI Bleeding Tube
Bleeding signal → circulation/perfusion state → IV access/laboratory and resuscitation → antiplatelet/anticoagulant context → upper/lower/uncertain source → risk stratification → endoscopy or imaging → haemostasis → repeat haemodynamic/haemoglobin receipt → rebleeding or stability → restart/adjust essential medicines → treat cause → recurrence prevention and follow-up.
1. The Owner Is the Acute Bleeding Trajectory
The Gastrointestinal & Liver Medicine Web owns digestive disease broadly. The Advanced Interventional Endoscopy Web owns advanced endoscopic intervention in its specific domain. Acute GI Bleeding owns the cross-owner emergency trajectory from blood loss to haemostasis and recurrence prevention.
2. Haemodynamic State Comes Before Perfect Source Certainty
Tachycardia, hypotension, syncope, altered perfusion or shock can indicate clinically significant blood loss. Initial care may need to restore circulation while localisation proceeds in parallel.
RFE rule: stabilise physiology without losing the evidence needed to find and stop the source.
3. Haemoglobin Is a Lagging Receipt
Early after acute haemorrhage, haemoglobin may not immediately reflect the full volume lost. Trends, clinical state, fluid administration and ongoing bleeding matter.
Anti-collapse rule: one haemoglobin value ≠ bleeding severity.
4. Upper GI Bleeding Has Its Own High-Risk Causes
Peptic ulcers, varices, mucosal tears, tumours and vascular lesions can all cause upper-GI bleeding. Endoscopy can diagnose and often treat the source during the same procedure.
5. Lower GI Bleeding Requires a Different Localisation Strategy
Diverticular bleeding, angioectasia, colitis, colorectal lesions and other causes can produce lower-GI bleeding. Current ACG guidance distinguishes risk-based lower-GI pathways and includes CT angiography for selected severe ongoing bleeding rather than assuming every patient follows one urgent-colonoscopy route.
6. Endoscopic Haemostasis Is a Procedure, Not a Diagnosis
Mechanical, thermal, injection and other endoscopic techniques may stop bleeding depending on lesion and location. The procedure receipt should preserve source found, treatment delivered, immediate haemostasis and rebleeding risk.
7. CT Angiography Can Find Active Bleeding Without Entering the Bowel
CT angiography can identify active contrast extravasation and help direct interventional radiology or surgery in selected ongoing bleeds.
The Radiology & Imaging Web owns image production and interpretation. Acute GI Bleeding owns how that evidence changes the haemostasis route.
8. Interventional Radiology Can Become the Haemostasis Owner
When endoscopy cannot control or access an ongoing bleed, angiography and embolisation may be appropriate in selected cases. The Interventional Radiology Web owns the image-guided haemostatic procedure.
9. Surgery Is a Rescue or Definitive Route, Not the Default
Some uncontrolled or recurrent bleeds require operative treatment, especially when endoscopic and radiological routes fail or the underlying disease itself requires surgery.
10. Anticoagulants and Antiplatelets Create a Parallel Risk Ledger
These medicines can increase bleeding severity while protecting against stroke, myocardial infarction or venous thrombosis. Stopping or reversing them can therefore create thrombotic risk.
Core distinction: bleeding present ≠ every antithrombotic should be stopped indefinitely.
11. Transfusion Restores Oxygen-Carrying Capacity; It Does Not Stop the Source
Blood transfusion may be required according to haemoglobin, haemodynamics, ongoing loss, cardiovascular context and current guideline strategy. It treats the consequence of bleeding while haemostasis treats the cause.
12. Variceal Bleeding Has a Portal-Hypertension Owner
When oesophageal or gastric varices bleed, the underlying problem is portal hypertension, often in chronic liver disease. Acute endoscopic control must therefore connect to liver/portal-pressure management and recurrence prevention.
13. Rebleeding Is a New State, Not a Repeat of the First Event
Recurrent haematemesis, melaena, haematochezia, haemodynamic deterioration or falling haemoglobin after initial haemostasis can reopen the diagnostic and intervention route.
The correction loop is source hypothesis → haemostasis → physiological receipt → rebleeding evidence → repeat localisation → new haemostasis route.
14. The Cause Must Be Treated After the Bleeding Stops
Ulcer disease, portal hypertension, diverticular disease, inflammatory disease, vascular lesions or malignancy each have different recurrence-prevention strategies. “Bleeding stopped” is therefore an intermediate receipt.
15. Evidence, Uncertainty and Correction
Acute GI bleeding decisions combine symptoms, haemodynamics, serial laboratory results, medication history, endoscopy and imaging. A source may be intermittent and disappear temporarily before testing, so negative evidence must be interpreted in context.
16. RFE: Did We Stop the Bleeding Without Losing the Disease Behind It?
The Medicine RFE asks whether timely, evidence-grounded and ethically authorised help reaches the human and improves outcomes without preventable harm. In GI bleeding, success means protecting perfusion, localising and controlling the source, balancing transfusion and antithrombotic risks, recognising rebleeding, treating the underlying cause and returning the person to stable function with a clear prevention plan.
eduKateAI Acute GI Bleeding Tube Card
- TRIGGER: haematemesis, melaena, haematochezia, syncope or acute anaemia?
- PHYSIOLOGY: pressure, pulse, perfusion and ongoing loss?
- SOURCE: upper, lower, small bowel or uncertain?
- MEDICINES: anticoagulant, antiplatelet, NSAID or other bleeding contributor?
- LABS: haemoglobin trend, platelets, coagulation and renal/liver state?
- LOCALISATION: endoscopy, colonoscopy, CT angiography or other?
- HAEMOSTASIS: endoscopic, embolisation, surgery or spontaneous cessation?
- TRANSFUSION: required and what clinical receipt followed?
- REBLEEDING: evidence present or absent?
- CAUSE: ulcer, varix, diverticular, vascular, inflammatory, tumour or other?
- RETURN: medicine restart, cause treatment and recurrence prevention?
Canonical External Sources
- American College of Gastroenterology — Clinical Guidelines
- Relevant current guidance: ACG Upper Gastrointestinal and Ulcer Bleeding guidance, 2023 updated Lower GI Bleeding guidance, and ACG-CAG antithrombotic management guidance.
Educational boundary: Acute gastrointestinal bleeding can be life-threatening. This page explains information architecture and does not determine bleeding severity, transfusion thresholds, medication reversal, timing of endoscopy or whether emergency radiological or surgical haemostasis is required.
